Stay updated on Nebulized Fentanyl in ILD Patients Clinical Trial
Sign up to get notified when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.

Latest updates to the Nebulized Fentanyl in ILD Patients Clinical Trial page
- Check3 days agoChange DetectedVisual/UI updates are present, but there are no changes to core study details (protocol, eligibility criteria, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference4%

- Check39 days agoChange DetectedAdds update label (v3.1.0) and removes several drug-safety sections (Drug Safety, Substandard Drugs, Counterfeit Drugs) from the page.SummaryDifference0.7%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has added significant content related to drug safety, including various drug classifications and solutions, while removing numerous specific medical conditions and drug categories.SummaryDifference5%

Stay in the know with updates to Nebulized Fentanyl in ILD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.